ATE255634T1 - Rekombinantes humanes erythropoietin mit vorteilhaftem glykosylierungsmuster - Google Patents

Rekombinantes humanes erythropoietin mit vorteilhaftem glykosylierungsmuster

Info

Publication number: ATE255634T1
Authority: AT; Austria
Prior art keywords: dna sequences; vectors; polypeptides; erythropoietin; aforedescribed
Prior art date: 1997-09-01

Application number

AT97115081T

Other languages

English (en)

Inventor

Mathias Dr Fibi

Peter Dr Hermentin

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-01

Filing date

1997-09-01

Publication date

2003-12-15

1997-09-01 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2003-12-15 Application granted granted Critical

2003-12-15 Publication of ATE255634T1 publication Critical patent/ATE255634T1/de

Links

230000013595 glycosylation Effects 0.000 title abstract 2
238000006206 glycosylation reaction Methods 0.000 title abstract 2
101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 title 1
101000920686 Homo sapiens Erythropoietin Proteins 0.000 title 1
102000044890 human EPO Human genes 0.000 title 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 6
229920001184 polypeptide Polymers 0.000 abstract 5
102000004196 processed proteins & peptides Human genes 0.000 abstract 5
108090000765 processed proteins & peptides Proteins 0.000 abstract 5
239000013598 vector Substances 0.000 abstract 4
102000003951 Erythropoietin Human genes 0.000 abstract 2
108090000394 Erythropoietin Proteins 0.000 abstract 2
230000004071 biological effect Effects 0.000 abstract 2
229940105423 erythropoietin Drugs 0.000 abstract 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
208000007502 anemia Diseases 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000001105 regulatory effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT97115081T 1997-09-01 1997-09-01 Rekombinantes humanes erythropoietin mit vorteilhaftem glykosylierungsmuster ATE255634T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97115081A EP0902085B1 (de)	1997-09-01	1997-09-01	Rekombinantes humanes Erythropoietin mit vorteilhaftem Glykosylierungsmuster

Publications (1)

Publication Number	Publication Date
ATE255634T1 true ATE255634T1 (de)	2003-12-15

Family

ID=8227297

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97115081T ATE255634T1 (de)	1997-09-01	1997-09-01	Rekombinantes humanes erythropoietin mit vorteilhaftem glykosylierungsmuster

Country Status (12)

Country	Link
US (1)	US6673609B1 (de)
EP (2)	EP0902085B1 (de)
JP (1)	JP4345077B2 (de)
KR (1)	KR100563017B1 (de)
AT (1)	ATE255634T1 (de)
AU (1)	AU743833B2 (de)
CA (1)	CA2303476A1 (de)
DE (1)	DE69726571T2 (de)
DK (1)	DK0902085T3 (de)
ES (1)	ES2208798T3 (de)
PT (1)	PT902085E (de)
WO (1)	WO1999011781A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2686899B1 (fr)	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
AU774989B2 (en) *	1998-10-23	2004-07-15	Amgen, Inc.	Methods and compositions for the prevention and treatment of anemia
US7304150B1 (en)	1998-10-23	2007-12-04	Amgen Inc.	Methods and compositions for the prevention and treatment of anemia
WO2000067776A1 (en) *	1999-05-11	2000-11-16	Ortho-Mcneil Pharmaceuticals, Inc.	Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
CZ299516B6 (cs) *	1999-07-02	2008-08-20	F. Hoffmann-La Roche Ag	Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
EP2213743A1 (de)	2000-04-12	2010-08-04	Human Genome Sciences, Inc.	Albuminfusionsproteine
DE60219961T8 (de)	2001-02-02	2008-04-17	Ortho-Mcneil Pharmaceutical, Inc.	Behandlung von neurologischen funktionsstörungen mit fructopyranosesulfamaten und erythropoetin
US6818613B2 (en)	2001-11-07	2004-11-16	Ortho-Mcneil Pharmaceutical, Inc.	Aqueous sustained-release formulations of proteins
WO2003045423A1 (en)	2001-11-28	2003-06-05	Ortho-Mcneil Pharmaceutical, Inc.	Erythropoietin dosing regimen for treating anemia
WO2005003296A2 (en)	2003-01-22	2005-01-13	Human Genome Sciences, Inc.	Albumin fusion proteins
AU2002364586A1 (en)	2001-12-21	2003-07-30	Delta Biotechnology Limited	Albumin fusion proteins
WO2003078959A2 (en)	2002-03-11	2003-09-25	Ortho Mcneil Pharmaceutical, Inc	Methods for shp1 mediated neuroprotection
US7553930B2 (en)	2003-01-06	2009-06-30	Xencor, Inc.	BAFF variants and methods thereof
EP2495308A1 (de)	2005-12-08	2012-09-05	Amgen Inc.	Verbesserte Herstellung von Glykoproteinen unter Verwendung von Mangan
CN101062407A (zh)	2006-04-29	2007-10-31	中国科学院上海生命科学研究院	促红细胞生成素在预防或治疗视网膜损伤中的用途
MX344166B (es)	2008-02-08	2016-12-07	Ambrx Inc	Leptina-polipeptidos modificados y sus usos.
BR122012024318A2 (pt)	2008-09-26	2019-07-30	Ambrx, Inc.	Polipeptídeos modificados de eritropoetina animal e seus usos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL77081A (en) *	1984-12-04	1999-10-28	Genetics Inst	Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US5641663A (en) *	1985-11-06	1997-06-24	Cangene Corporation	Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from steptomyces
US4954437A (en) *	1986-09-15	1990-09-04	Integrated Genetics, Inc.	Cell encoding recombinant human erythropoietin
DE3923963A1 (de) *	1989-07-20	1991-01-31	Behringwerke Ag	Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung
JPH03151399A (ja) *	1989-11-07	1991-06-27	Snow Brand Milk Prod Co Ltd	変異ヒトエリスロポエチン
WO1992006116A1 (en) *	1990-09-28	1992-04-16	Ortho Pharmaceutical Corporation	Hybrid growth factors
CN1057534C (zh) *	1993-08-17	2000-10-18	柯瑞英-艾格公司	促红细胞生成素类似物
US9505465B2 (en) *	2014-12-15	2016-11-29	Fundamental Consulting Services Inc.	Apparatus and method for attaching watercraft

1997
- 1997-09-01 ES ES97115081T patent/ES2208798T3/es not_active Expired - Lifetime
- 1997-09-01 EP EP97115081A patent/EP0902085B1/de not_active Expired - Lifetime
- 1997-09-01 DE DE69726571T patent/DE69726571T2/de not_active Expired - Lifetime
- 1997-09-01 DK DK97115081T patent/DK0902085T3/da active
- 1997-09-01 PT PT97115081T patent/PT902085E/pt unknown
- 1997-09-01 AT AT97115081T patent/ATE255634T1/de active
1998
- 1998-08-26 WO PCT/EP1998/005399 patent/WO1999011781A1/en not_active Ceased
- 1998-08-26 KR KR1020007002146A patent/KR100563017B1/ko not_active Expired - Fee Related
- 1998-08-26 AU AU95337/98A patent/AU743833B2/en not_active Ceased
- 1998-08-26 CA CA002303476A patent/CA2303476A1/en not_active Abandoned
- 1998-08-26 JP JP2000508791A patent/JP4345077B2/ja not_active Expired - Fee Related
- 1998-08-26 US US09/486,222 patent/US6673609B1/en not_active Expired - Fee Related
- 1998-08-26 EP EP98948868A patent/EP1007679A1/de not_active Ceased

Also Published As

Publication number	Publication date
EP1007679A1 (de)	2000-06-14
DE69726571T2 (de)	2004-11-04
KR20010023500A (ko)	2001-03-26
WO1999011781A1 (en)	1999-03-11
ES2208798T3 (es)	2004-06-16
EP0902085B1 (de)	2003-12-03
DK0902085T3 (da)	2004-04-05
JP4345077B2 (ja)	2009-10-14
US6673609B1 (en)	2004-01-06
KR100563017B1 (ko)	2006-03-22
PT902085E (pt)	2004-02-27
EP0902085A1 (de)	1999-03-17
DE69726571D1 (de)	2004-01-15
AU743833B2 (en)	2002-02-07
AU9533798A (en)	1999-03-22
JP2001514851A (ja)	2001-09-18
CA2303476A1 (en)	1999-03-11

Legal Events

Date

Code

Title

Description

2004-05-15

UEP

Publication of translation of european patent specification

Ref document number: 0902085

Country of ref document: EP

Publication	Publication Date	Title
ATE255634T1 (de)	2003-12-15	Rekombinantes humanes erythropoietin mit vorteilhaftem glykosylierungsmuster
Marder et al.	1984	Molecular architecture of the rapidly metabolized 32-kilodalton protein of photosystem II. Indications for COOH-terminal processing of a chloroplast membrane polypeptide.
ATE182901T1 (de)	1999-08-15	Für androgen-rezeptor-protein kodierende dna
RU95115239A (ru)	1997-03-27	Аналог эритропоэтина
DE69833784D1 (de)	2006-05-04	Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
ATE352626T1 (de)	2007-02-15	Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
CY1112655T1 (el)	2016-02-10	Γλυκοζυλιωμενη ιl-7, παρασκευη και χρησεις
DE60018171D1 (de)	2005-03-24	Verwendung von adenovirus e1 protein sequenzen kodierenden, zur herstellung von rekombinanten proteinen in menschlichen zellen.
IS6927A (is)	2003-08-26	Nýjar sameindir skyldar interferon-beta
DE69840230D1 (de)	2009-01-02	Polypeptide mit prolyldipeptidylaminopeptidase-aktivität und dafür kodierende nukleinsäuren
DE69930955D1 (de)	2006-05-24	Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ATE56728T1 (de)	1990-10-15	Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
ATE226634T1 (de)	2002-11-15	Fibronektin bindendes protein
NO943949D0 (no)	1994-10-18	DNA som koder for proteinkomplekser med faktor VIII-C-aktivitet, samt fremstilling derav
DE3584579D1 (de)	1991-12-12	Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
NZ503235A (en)	2002-08-28	Amino-terminally truncated RANTES as chemokine antagonists
DE69837475D1 (de)	2007-05-16	Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DE3751893D1 (de)	1996-10-10	Polypeptid und dessen Herstellung
HRP940432B1 (en)	2003-10-31	Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
DE60143561D1 (de)	2011-01-13	Nukleinsäuren kodierend für polypeptide mit chips aktivität
NO874704D0 (no)	1987-11-11	Minaktivin fremstilt ved rekombinant dna-teknikk.
DE602004019556D1 (de)	2009-04-02	Neues plexin-polypeptid, dieses codierende dna und verwendung davon